TNSN99051A1 - Halogenures de phenoxyphenylsulfonyle et procede pour leur preparation - Google Patents

Halogenures de phenoxyphenylsulfonyle et procede pour leur preparation

Info

Publication number
TNSN99051A1
TNSN99051A1 TNTNSN99051A TNSN99051A TNSN99051A1 TN SN99051 A1 TNSN99051 A1 TN SN99051A1 TN TNSN99051 A TNTNSN99051 A TN TNSN99051A TN SN99051 A TNSN99051 A TN SN99051A TN SN99051 A1 TNSN99051 A1 TN SN99051A1
Authority
TN
Tunisia
Prior art keywords
preparation
compounds
matrix metalloproteinase
phenoxyphenylsulfonyl
halides
Prior art date
Application number
TNTNSN99051A
Other languages
English (en)
Inventor
Michael Hawkins Joel
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN99051A1 publication Critical patent/TNSN99051A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C301/00—Esters of sulfurous acid
    • C07C301/02—Esters of sulfurous acid having sulfite groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/41—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C07C309/42—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/75—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'INVENTION A POUR OBJET DES COMPOSES NOUVEAUX CONSISTANT EN HALOGENURES DE PHENOXYPHENYLSULFONYLE. CES COMPOSES SONT DES INTERMEDIAIRES UTILES POUR LA PREPARATION DES COMPOSES INHIBITEURS DES METALLOPROTEINASES DE MATRICE. APPLICATION : UTILISATION DE CES INTERMEDIAIRES POUR LA PREPARATION D’INHIBITEURS DE METALLOPROTEINASES DE MATRICE POUR LE TRAITEMENT DES DIVERSES MALADIES. -L'INVENTION A POUR OBJET DES COMPOSES NOUVEAUX CONSISTANT EN HALOGENURES DE PHENOXYPHENYLSULFONYLE. CES COMPOSES SONT DES INTERMEDIAIRES UTILES POUR LA PREPARATION DES COMPOSES INHIBITEURS DES METALLOPROTEINASES DE MATRICE. APPLICATION : UTILISATION DE CES INTERMEDIAIRES POUR LA PREPARATION D’INHIBITEURS DE METALLOPROTEINASES DE MATRICE POUR LE TRAITEMENT DES DIVERSES MALADIES.
TNTNSN99051A 1998-04-10 1999-04-07 Halogenures de phenoxyphenylsulfonyle et procede pour leur preparation TNSN99051A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8139398P 1998-04-10 1998-04-10

Publications (1)

Publication Number Publication Date
TNSN99051A1 true TNSN99051A1 (fr) 2005-11-10

Family

ID=22163859

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99051A TNSN99051A1 (fr) 1998-04-10 1999-04-07 Halogenures de phenoxyphenylsulfonyle et procede pour leur preparation

Country Status (42)

Country Link
US (2) US6118016A (fr)
EP (1) EP0949246B1 (fr)
JP (1) JP3694419B2 (fr)
KR (1) KR100329901B1 (fr)
CN (1) CN1238329A (fr)
AP (1) AP1155A (fr)
AR (1) AR016205A1 (fr)
AT (1) ATE233729T1 (fr)
AU (1) AU758297B2 (fr)
BG (1) BG103321A (fr)
BR (1) BR9902041A (fr)
CA (1) CA2268679C (fr)
CO (1) CO4810300A1 (fr)
DE (1) DE69905633T2 (fr)
DK (1) DK0949246T3 (fr)
DZ (1) DZ2755A1 (fr)
EA (1) EA001756B1 (fr)
ES (1) ES2192021T3 (fr)
GT (1) GT199900044A (fr)
HR (1) HRP990107B1 (fr)
HU (1) HU221635B1 (fr)
ID (1) ID23645A (fr)
IL (1) IL129330A (fr)
IN (1) IN191233B (fr)
IS (1) IS5020A (fr)
MA (1) MA24834A1 (fr)
NO (1) NO991679L (fr)
NZ (1) NZ335106A (fr)
OA (1) OA11032A (fr)
PA (1) PA8469801A1 (fr)
PE (1) PE20000416A1 (fr)
PL (1) PL332452A1 (fr)
SG (1) SG75169A1 (fr)
SI (1) SI0949246T1 (fr)
SK (1) SK44999A3 (fr)
TN (1) TNSN99051A1 (fr)
TR (1) TR199900757A2 (fr)
TW (1) TW539664B (fr)
UA (1) UA59373C2 (fr)
UY (1) UY25472A1 (fr)
YU (1) YU18299A (fr)
ZA (1) ZA992628B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
ES2425013T3 (es) * 2002-06-12 2013-10-10 Symphony Evolution, Inc. Inhibidores de ADAM-10 humana
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
JP5830534B2 (ja) 2010-07-09 2015-12-09 ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ 化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE844004C (de) * 1944-08-06 1952-07-14 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Sulfonsaeureestern
US4032506A (en) * 1973-12-28 1977-06-28 General Electric Company Flame retardant polycarbonate composition
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5340489A (en) * 1992-06-05 1994-08-23 The Dow Chemical Company Aryl arenesulfonates and a method of lubrication using the aryl arenesulfonates
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
US6153609A (en) * 1996-08-23 2000-11-28 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
TR199901849T2 (xx) * 1997-02-03 2000-02-21 Pfizer Products Inc. Arils�lfonilamino hidroksamik asit t�revleri.
WO1998050348A1 (fr) * 1997-05-09 1998-11-12 Agouron Pharmaceuticals, Inc. Inhibiteurs de metalloproteases, compositions pharmaceutiques les contenant et leurs utilisations pharmaceutiques
ATE217863T1 (de) * 1997-08-08 2002-06-15 Pfizer Prod Inc Arylsulfonylaminohydroxamsäurederivate
ATE263147T1 (de) * 1997-08-08 2004-04-15 Pfizer Prod Inc Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
PA8469401A1 (es) * 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
AU758297B2 (en) 2003-03-20
TW539664B (en) 2003-07-01
AP9901509A0 (en) 1999-06-30
SI0949246T1 (en) 2003-06-30
US6118016A (en) 2000-09-12
GT199900044A (es) 2000-09-14
PE20000416A1 (es) 2000-05-24
EA199900282A2 (ru) 1999-10-28
EP0949246A1 (fr) 1999-10-13
HU9901042D0 (en) 1999-06-28
NO991679L (no) 1999-10-11
JPH11322704A (ja) 1999-11-24
DE69905633D1 (de) 2003-04-10
IS5020A (is) 1999-10-11
NZ335106A (en) 2000-09-29
CN1238329A (zh) 1999-12-15
EA001756B1 (ru) 2001-08-27
CA2268679C (fr) 2004-07-27
TR199900757A3 (tr) 1999-11-22
AR016205A1 (es) 2001-06-20
ID23645A (id) 2000-05-04
TR199900757A2 (xx) 1999-11-22
BG103321A (en) 2001-08-31
JP3694419B2 (ja) 2005-09-14
HRP990107A2 (en) 2000-02-29
HU221635B1 (hu) 2002-12-28
HUP9901042A2 (hu) 1999-12-28
ZA992628B (en) 2000-10-09
NO991679D0 (no) 1999-04-09
BR9902041A (pt) 2000-05-02
PA8469801A1 (es) 2000-09-29
EP0949246B1 (fr) 2003-03-05
SG75169A1 (en) 2000-09-19
YU18299A (sh) 2002-11-15
IL129330A0 (en) 2000-02-17
KR100329901B1 (ko) 2002-03-22
AP1155A (en) 2003-06-30
UA59373C2 (uk) 2003-09-15
KR19990082980A (ko) 1999-11-25
MA24834A1 (fr) 1999-12-31
OA11032A (en) 2002-02-06
AU2369299A (en) 1999-10-21
PL332452A1 (en) 1999-10-11
DE69905633T2 (de) 2003-11-06
HRP990107B1 (en) 2003-10-31
ATE233729T1 (de) 2003-03-15
IL129330A (en) 2003-12-10
UY25472A1 (es) 1999-11-17
HUP9901042A3 (en) 2000-06-28
DZ2755A1 (fr) 2003-09-15
SK44999A3 (en) 2000-09-12
ES2192021T3 (es) 2003-09-16
CO4810300A1 (es) 1999-06-30
CA2268679A1 (fr) 1999-10-10
DK0949246T3 (da) 2003-04-07
US20010011143A1 (en) 2001-08-02
EA199900282A3 (ru) 2000-04-24
IN191233B (fr) 2003-10-11

Similar Documents

Publication Publication Date Title
PT874808E (pt) Inibidores bifenil-hidroxamato de metaloproteinases de matriz
NO963499L (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
ATE232536T1 (de) N-(2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-
TNSN00121A1 (fr) Composes nouveaux inhibiteurs de metalloproteases, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26901A1 (fr) Nouvelle composition pharmaceutique
FI971412A (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä
TNSN99055A1 (fr) Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DE69616333T2 (de) Thip zur behandlung von schlafstörungen
TNSN99053A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
ATE219058T1 (de) Alpha-substituierte arylsulphonamidohydroxamsaüre als tnf-alpha und matrix-metalloproteinase- inhibitoren
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
TNSN99156A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97078A1 (fr) Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
TNSN00230A1 (fr) Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2, 3,4-tetrahydroquinoleine
EE200000093A (et) Agrekanaasi ja maatriksmetalloproteinaaside uudsed inhibiitorid artriidi käitlemiseks
DK0946502T3 (da) Sulfonamidinhibitorer for det interleukin-1beta-omdannende enzym
IT1277904B1 (it) Metodo per determinare l'attivita' terapeutica di composti inibitori di metalloproteinasi, nuovi composti inibitori, e loro impiego
TNSN99051A1 (fr) Halogenures de phenoxyphenylsulfonyle et procede pour leur preparation
BR9713207A (pt) Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz
TNSN02038A1 (fr) Composes conjugues de pregabaline et de lactose nouveaux, et compositions les contenant
TNSN99002A1 (fr) Composes nouveaux inhibiteurs de mmp, procede pour leur preparation et compositions pharmaceutiques les contenant
ATE237630T1 (de) Peptidartige stoffe, die metalloproteinasen und die tnf-freisetzung hemmen, und ihre therapeutische verwendung
DZ3512A1 (fr) Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de médicaments
TNSN00142A1 (fr) Complexe d'eletriptan et d'une sulfobutylether- betacyclodextrine, procede pour sa preparation et compositions pharmaceutiques les contenant.
FR2795398B1 (fr) Procede et installation pour le traitement d'effluents agricoles